NCT03015090View on ClinicalTrials.gov

Association Study Between CYP1A2 Gene Polymorphisms and Metabolism of Theophylline

NACompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 1, 2017

Study Completion Date

June 1, 2017

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Theophylline

After oral theophylline 200mg per day for one week, blood sample will be collected for determining plasma concentrations of theophylline and it's metabolites and the genotypes of CYP1A2

Trial Locations (1)

844000

Kashgar 1st People's Hospital, Kashgar

All Listed Sponsors

collaborator

Southern Medical University, China

OTHER

lead

XiaoGuang Zou

OTHER

NCT03015090 - Association Study Between CYP1A2 Gene Polymorphisms and Metabolism of Theophylline | Biotech Hunter | Biotech Hunter